M. Perch (Gentofte, Denmark), R. Vos (Leuven, Belgium)
Late Breaking Abstract - Prediction of chronic lung allograft rejection (CLAD) by measurement of peripheral T cells linked to the inhibitory check-point HLA-G.
O. Brugière (Suresnes, France), D. Mouren (Suresnes, France), I. Kuzniak (PAris, France), E. Carosella (Paris, France), J. Le Maoult (Paris, France), N. Rouas-Freiss (Paris, France)
|     |
The use of mTOR inhibitors is associated with improved survival in lung transplant recipients
Y. Lebel-Shostak (Petah-Tikva, Israel), B. Pertzov (Petah-Tikva, Israel), O. Grossberger (Petah-Tikva, Israel), D. Rosengarten (Petah-Tikva, Israel), D. Shitenberg (Petah-Tikva, Israel), M. Heshing (Petah-Tikva, Israel), S. Amor (Petah-Tikva, Israel), M. Kramer (Petah-Tikva, Israel)
| |
Real life experience in mTOR-inhibitors after lung transplantation
S. Bos (Leuven, Belgium), L. De Sadeleer (Leuven, Belgium), B. Vanaudenaerde (Leuven, Belgium), J. Yserbyt (Leuven, Belgium), L. Dupont (Leuven, Belgium), L. Godinas (Leuven, Belgium), G. Verleden (Leuven, Belgium), R. Vos (Leuven, Belgium)
| |
Intra-alveolar neutrophil-derived microvesicles predict development of primary graft dysfunction after lung transplantation.
S. Soni (London, United Kingdom), R. Romano (London, United Kingdom), K. O'Dea (London, United Kingdom), B. Patel (London, United Kingdom), K. Tatham (London, United Kingdom), M. Koh (London, United Kingdom), D. Tsiridou (London, United Kingdom), A. Simon (London, United Kingdom), L. Thakuria (London, United Kingdom), M. Wilson (London, United Kingdom), A. Reed (London, United Kingdom), N. Marczin (London, United Kingdom), M. Takata (London, United Kingdom)
| |
Exhaled breath particles - a potential noninvasive method to detect and monitor chronic allograft dysfunction in lung transplant recipients
A. Niroomand (Lund, Sweden), O. Hallgren (Lund, Sweden), D. Wagner (Lund, Sweden), S. LINDSTEDT (Lund, Sweden)
| |
Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant
M. Driskel (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom), M. Al-Aloul (Manchester, United Kingdom)
| |
Plasma levels of acute phase proteins in patients from the multicenter longitudinal French Cohort in Lung Transplantation (COLT): a pilot study
S. Janciauskiene (Hannover, Germany), P. Royer (Nantes, France), J. Fuge (Hannover, Germany), S. Wrenger (Hannover, Germany), J. Chorostowska (Warsaw, Poland), H. Zhu (Zhengzhou, China), T. Welte (Hannover, Germany), M. Reynaud-Gaubert (Marseilles, France), A. Roux (Nantes, France), A. Tissot (Nantes, France), A. Magnan (Nantes, France)
| |
Usefulness of lactate dehydrogenase and serum C-reactive protein in the follow-up of patients with lung transplantation
S. Hermoso De Mendoza Aristegui (Palma de Mallorca, Spain), L. Ramón (Palma de Mallorca, Spain), C. Suárez (Palma de Mallorca, Spain), C. Bravo (Barcelona, Spain), C. Berastegui (Barcelona, Spain), J. Sauleda (Palma de Mallorca, Spain), E. Sala (Palma de Mallorca, Spain), F. Verdú (Palma de Mallorca, Spain)
| |